Advisors to Unipharms Foundation
Ascher Resources Limited
Alan Sheppard has over 45 years extensive experience within the healthcare industry, including innovator R&D pharmaceuticals, OTC and generic companies and working with government departments, law firms, venture capital companies and industry associations.
Ascher Resources provides the pharmaceutical industry with strategic insights and support for global expansion, portfolio management, mergers and acquisitions, generic and biosimilar market strategies, market access and payer analysis.
Alan is a consultant with the QuintilesIMS Thought Leadership team, leading the global generics and biosimilars arm. In this role he is responsible for developing the services provided to the industry and its associations on generic medicines and biosimilars through a combination of consulting, information and market analyses.
Previous positions held include Executive Vice-President, Europe Generics, for Dr Reddy’s Laboratories Ltd; Vice-President Global Corporate Strategy PLIVA and Vice-President Western Europe; European Marketing Director and Deputy Managing Director, Medeva; General Manager, Rhône-Poulenc Rorer UK; Marketing Director, Revlon Healthcare; General Manager, Institute Mérieux UK, and management roles with Servier Laboratories, SmithKline & French and Upjohn.
Other roles have included:
Chairman of the Technical Advisory Group for the Access to Medicines Foundation; Expert witness on patent litigation issues and their commercial impact; Guest lecturer, University of Wales medicines faculty specialising in providing training for pharmaceutical physicians within the British Association of Pharmaceutical Physicians programme.
Alan was a long serving member of the Prescription Medicines Code of Practice Authority Appeals Board, a Fellow of the Chartered Institute of Management, and Fellow of the International Doctors’ Association and a Member of the Chartered Institute of Marketing.